The largest analysis of real-world outcomes with bispecific antibodies after CAR-T failure in LBCL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-02-11
Просмотров: 31
Описание:
In this video, Megan Melody, MD, Northwestern University Feinberg School of Medicine, Chicago, IL, discusses the results of the largest retrospective analysis to date examining the real-world outcomes with bispecific antibody treatment following CAR-T failure in patients with large B-cell lymphoma (LBCL). Dr Melody notes that the efficacy of bispecific antibodies is not significantly reduced in patients who have previously received CAR T-cell therapy, making them a valuable therapeutic option in this setting. This interview took place virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
